TMFFishBiz’s Activity

Yesterday

NL

Article

TMFFishBiz published an article 8:02 AM

Investors' Love/Hate Relationship with MannKind Corp. Stock

Emotions run high when it comes to this biotech.

Thu Mar 19

NL

Article

TMFFishBiz published an article 12:01 PM

The Most Expensive Health Insurance Stock Worth Buying

It's stock might seem pricey, but this health insurer still presents a bargain for smart investors.

Wed Mar 18

NL

Article

TMFFishBiz published an article 12:00 AM

Can This Biotech Stock Go from Good to Great?

Alexion Pharmaceuticals is a really good biotech stock. Does greatness await?

Sun Mar 15

NL

Article

TMFFishBiz published an article 11:01 AM

1 Expensive Biotech Stock Worth Buying

It's expensive -- but this biotech stock still looks like a bargain.

Sat Mar 14

NL

Article

TMFFishBiz published an article 1:03 PM

The Single Worst Practice of the Health Insurance Industry

What's the worst of the bad things that health insurers do?

Mon Mar 9

NL

Article

TMFFishBiz published an article 12:00 AM

3 Biotech Stocks Wall Street Loves

Wall Street analysts love these biotech stocks. Should you?

Sun Mar 8

NL

Article

TMFFishBiz published an article 11:04 AM

3 Healthcare Stocks With Tantalizing Yet Treacherous Dividends

Want dividend yields of 4% and higher? Check out these 3 healthcare stocks -- but be careful.

Wed Feb 25

Rule Breakers article.

TMFFishBiz published an update. 10:00 AM

Rule Breakers article.

TMFFishBiz published an update. 9:49 AM

Tue Feb 24

NL

Article

TMFFishBiz published an article 12:02 PM

3 Things to Watch with Catamaran Corporation's Q4 Results

Will Catamaran have the wind at its sails when it announces Q4 results this week?

NL

Article

TMFFishBiz published an article 11:38 AM

Celldex Therapeutics Inc. Q4 Earnings Overshadowed by FDA News

Celldex reports fourth-quarter earnings -- but the big story is an FDA decision on rindopepimut.

NL

Article

TMFFishBiz published an article 8:02 AM

Billions on the Line in the Next Drug Pricing War

Could approval of two new cholesterol drugs lead to another high stakes pricing war?

Thu Feb 19

NL

Article

TMFFishBiz published an article 8:02 AM

11.7 Billion Reasons Gilead Sciences, Inc. Should Keep Winning

This four-letter word points to great things ahead for Gilead Sciences: C-A-S-H.

Tue Feb 10

Stock Advisor article.

TMFFishBiz published an update. 11:08 AM

NL

Article

TMFFishBiz published an article 9:16 AM

CVS Health's PBM Business Delivers Solid Q4 Results

Not selling tobacco products hurt CVS Health, but a strong performance from its PBM segment keeps the company on a roll.

NL

Article

TMFFishBiz published an article 12:00 AM

5 Things CVS Health's Management Wants You to Know

What you need to know from CVS Health's Q4 earnings call.

Fri Feb 6

Rule Breakers article.

TMFFishBiz published an update. 9:39 AM

Thu Feb 5

NL

Article

TMFFishBiz published an article 6:15 PM

What Should Investors Make of Athenahealth, Inc.'s Q4 Results?

Athenahealth beats expectations on revenue and earnings in Q4 -- but a few areas could cause concern for investors.

Rule Breakers article.

TMFFishBiz published an update. 10:00 AM

Wed Feb 4

NL

Article

TMFFishBiz published an article 5:21 PM

3 Warning Signs to Watch for Athenahealth, Inc.

Investors don't want any of these factors to loom large with athenahealth's upcoming Q4 results.

Show More Activity ...

CAPS Stats & Trivia

CAPS Player Rating 47.62
Player Rank 39367 out of 75149
Score 78.58
Score Change Today +16.88
Accuracy 42.11%
Active Picks 10
Total Picks 19
Best Pick QCOR.DL (+221.68)
Worst Pick AMRN (-107.70)
Average Score per Pick 4.14
Charms Earned 4
Highest Rated Favorite No Favorites Selected
Go to TMFFishBiz’s CAPS page

Boards Stats & Trivia

Board Posts 0
Recs Received 0
People who have rec'd these posts 0
Recs to Posts Ratio (last 30 days) N/A
Threads Started 0
Threads Started Percentage 0.00 %
Most Frequent Board N/A
Very First Post N/A
Percentage of Posts Rec'd 100.00 %
Show TMFFishBiz’s 10 Latest Posts